Yahoo Web Search

  1. The case involves Innate Immunotherapeutics, an Australian biotech company that was testing the drug MIS416 for treatment of multiple sclerosis. Basically, prosecutors allege that ...

  2. Associations for people suffering from five disabilities — Hemophilia, Parkinson’s Disease, Thalassemia, Sickle Cell Disease and Multiple Sclerosis — sent a letter demanding reservation ...

  3. Biogen has been searching for new growth drivers lately, thanks to the continued declines in its flagship multiple sclerosis franchise resulting from increasing levels of competition ...

  4. The charges against Collins stem from his involvement with Innate Immunotherapeutics Ltd., a drug maker based in Sydney whose primary business was the research and development of a medication ...

  5. Rosemary Maseri was diagnosed with multiple sclerosis years ago. Maseri, 58, says she was prescribed opioids at age 36 after breaking a leg and getting a bone infection. "I was ...

  6. The company is focused on oncology, multiple sclerosis, infertility, growth disorders, selected cardiovascular and metabolic diseases, women’s and children’s health, cough and ...

  7. The study now published in the Journal of Neurochemistry* reveals the implications for both recreational users and people who use the drug to combat epilepsy, multiple sclerosis ...

  8. Ramadan, who took leave from his post at Oxford University after the allegations surfaced, has also complained that his imprisonment has made it more difficult for him to receive treatment for ...

  9. There are many advances to help with physical changes from Multiple Sclerosis, but very little to treat the memory and behavior changes. Local doctors are trying a different approach ...

  10. The company developed a drug intended to treat Secondary Progressive Multiple Sclerosis. Collins has denied any wrongdoing.

  1. 12345607 results